<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the molecular defect causing <z:chebi fb="1" ids="47775">high density lipoprotein cholesterol</z:chebi> (<z:chebi fb="0" ids="47775">HDL-C</z:chebi>) deficiency in a male proband and his family members </plain></SENT>
<SENT sid="1" pm="."><plain>Amplification and sequencing of genomic DNA disclosed a novel base-pair substitution at residue 159 in the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> (apo) A-I gene </plain></SENT>
<SENT sid="2" pm="."><plain>This substitution resulted in the loss of an AviII restriction site and a predicted substitution of leucine with proline at residue 159 </plain></SENT>
<SENT sid="3" pm="."><plain>Restriction enzyme analysis demonstrated absence of the AviII site in 19 of 40 biological family members </plain></SENT>
<SENT sid="4" pm="."><plain>Compared with familial controls, subjects with the apoA-I(Zavalla) variant had reduced <z:chebi fb="0" ids="47775">HDL-C</z:chebi> (1.16 versus 0.27 mmol/L, P&lt;0.0001), apoA-I (38.7 versus 124.4 mg/dL, P&lt;0.0001), and apoA-II (14.3 versus 19.0 mg/dL, P&lt;0.0001) levels </plain></SENT>
<SENT sid="5" pm="."><plain>Two subjects who have developed <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> to date possess additional <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Other heterozygotes for apoA-I(Zavalla) are presently without symptomatic <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>This study identifies a monogenic cause of <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e>, with the single base-pair substitution having a dominant effect on the low <z:chebi fb="0" ids="47775">HDL-C</z:chebi> phenotype </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, it extends recent observations that <z:chebi fb="0" ids="47775">HDL-C</z:chebi> deficiency states may be more prone to the development of <z:hpo ids='HP_0005181'>premature coronary artery disease</z:hpo> when accompanied by additional <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
</text></document>